Bahl & Gaynor’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,597
Closed -$207K 343
2022
Q4
$207K Buy
+1,597
New +$207K ﹤0.01% 330